Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
EIPG Newsletter
Politics & Business
Politics & Business
The EU Commission published the new Pharmaceutical Strategy
Giuliana Miglierini
-
18 December 2020
0
Barriers to generic and biosimilar entry on the market
Giuliana Miglierini
-
25 November 2020
0
How the future of health systems may look like
Giuliana Miglierini
-
28 October 2020
0
How the pharmaceutical market will look like in 2026
Giuliana Miglierini
-
17 September 2020
0
Lessons learnt and preparedness for the second-wave pandemic
Giuliana Miglierini
-
28 August 2020
0
The technological agenda of the next EU Council’s presidencies
Giuliana Miglierini
-
22 July 2020
0
New market opportunities in the post-pandemic era
Giuliana Miglierini
-
18 June 2020
0
New M&A dynamics in an uncertain Covid-19 environment
Giuliana Miglierini
-
20 May 2020
0
The EU’s new Industrial and Pharmaceutical Strategies
Giuliana Miglierini
-
17 April 2020
0
The impact of Covid-19 on drug shortages
Giuliana Miglierini
-
26 March 2020
0
1
2
3
4
Page 1 of 4
